ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,474,612 | +29.3% | 999,249 | +25.4% | 0.03% | +34.8% |
Q2 2023 | $15,834,900 | +47.1% | 796,925 | +26.8% | 0.02% | +35.3% |
Q1 2023 | $10,766,445 | +147.8% | 628,514 | +183.1% | 0.02% | +112.5% |
Q4 2022 | $4,344,540 | -48.0% | 222,000 | +17.6% | 0.01% | -38.5% |
Q2 2021 | $8,357,000 | -0.2% | 188,698 | 0.0% | 0.01% | -7.1% |
Q1 2021 | $8,373,000 | -54.0% | 188,698 | -43.2% | 0.01% | -56.2% |
Q4 2020 | $18,215,000 | +202.2% | 332,143 | +26.0% | 0.03% | +166.7% |
Q3 2020 | $6,027,000 | -32.0% | 263,642 | -37.8% | 0.01% | -36.8% |
Q2 2020 | $8,867,000 | +85.3% | 423,637 | +23.5% | 0.02% | +46.2% |
Q1 2020 | $4,785,000 | +1.9% | 343,000 | +66.2% | 0.01% | +30.0% |
Q4 2019 | $4,698,000 | – | 206,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |